Conference Coverage

VIDEO: RBCs have extended shelf life, randomized trial shows


 

AT ASH 2015

References

ORLANDO – Stored red blood cells kept for longer than a few weeks do not impair outcomes or harm the patients who receive them, Dr. Christine Cserti-Gazdewich reported at the annual meeting of the American Society of Hematology.

In a randomized clinical trial conducted in Kanpala, Uganda, where severe anemia with lactic acidosis is common, children who received RBCs that had been stored from 25-35 days had outcomes that were not inferior to those of children who received RBCs delivered within 10 days of collection. The findings have significant, positive implications for countries and geographic regions where there are chronic shortages of blood products, said Dr. Cserti-Gazdewich, of Toronto General Hospital.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

New Data Support Continuing Hydroxyurea for Pediatric Sickle Cell
MDedge Pediatrics
Sickle cell crises curtailed with experimental cellular adhesion inhibitor
MDedge Pediatrics
NHLBI expert panel issues guideline on sickle cell disease
MDedge Pediatrics
Sickle cell anemia trial halted because of early success
MDedge Pediatrics
Stem cells from sickle cell disease patients used to generate gene-corrected cells
MDedge Pediatrics
Hydroxyurea boosts O2 saturations in children with sickle cell disease
MDedge Pediatrics
Antibiotics to reduce microbiota may improve treatment of sickle-cell disease
MDedge Pediatrics
ASH: Oral drug offers alternative to lifelong transfusions in sickle cell
MDedge Pediatrics